Researchers
Below are researchers funded by the Kenneth Rainin Foundation who are working in immunity and inflammation.

Jean-Frederic Colombel, MD
Professor, Icahn School of Medicine at Mount Sinai; Director, Helmsley IBD Center; Former Grantee
By coordinating collaborative multi-disciplinary research efforts and public-private consortium, Dr. Colombel implements major clinical trials that have the potential to significantly improve treatments for patients across the spectrum of IBD.

Marco Colonna, MD
Professor, Washington University School of Medicine in St. Louis, Current Grantee
The Colonna lab is broadly interested in innate immunity, focused in two main areas related to IBD: 1) innate lymphoid cells in mucosal immunity and 2) plasmacytoid dendritic cells and IFNalpha/beta in host defense and autoimmunity.

Michael Davis, PhD
Professor, University of Missouri, Former Grantee
Dr. Davis’s lab focuses on the mechanical and electrophysiological properties of lymphatic smooth muscle and endothelium and how dysfunction of those cell types contributes to lymphedema.

Lee Denson, MD
Professor, Cincinnati Children’s Hospital Medical Center, Current Grantee
Dr. Denson’s multi-center research program focuses on discovering underlying mechanisms and better therapeutic approaches in chronic inflammation, growth and mucosal healing related to adult and pediatric patients with IBD.

Gretchen Diehl, PhD
Associate Professor, Memorial Sloan Kettering Cancer Center, Former Grantee
The Gretchen Diehl lab aims to understand the cellular and molecular processes limiting inflammation against the microbiota, with a focus on CX3CR1 expressing mononuclear phagocyte, a cell lineage they believe is critical in regulating homeostasis.

Arif Ekici, PhD
Institute of Human Genetics, University Hospital Erlangen, Former Grantee
Dr. Ekici is using the newest technology for high-throughput profiling and data analysis in a broad spectrum of human genetics research.